AKI in COVID-19–Associated Multisystem Inflammatory Syndrome in Children (MIS-C) | Zendy

Marissa Lipton | Zendy; Ruchi Mahajan | Zendy; Catherine R. Kavanagh | Zendy; Carol Shen | Zendy; Ibrahim Batal | Zendy; Samriti Dogra | Zendy; Namrata G. Jain | Zendy; Fangming Lin | Zendy; Natalie Uy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

AKI in COVID-19–Associated Multisystem Inflammatory Syndrome in Children (MIS-C)

Author(s) -

Marissa Lipton,

Ruchi Mahajan,

Catherine R. Kavanagh,

Carol Shen,

Ibrahim Batal,

Samriti Dogra,

Namrata G. Jain,

Fangming Lin,

Natalie Uy

Publication year - 2021

Publication title -

kidney360

Language(s) - English

Resource type - Journals

ISSN - 2641-7650

DOI - 10.34067/kid.0005372020

Subject(s) - medicine , procalcitonin , acute kidney injury , cohort , retrospective cohort study , covid-19 , pediatrics , sepsis , disease , infectious disease (medical specialty)

Multisystem inflammatory syndrome in children (MIS-C) is a recently identified entity in association with COVID-19. AKI has been widely reported in patients with primary COVID-19 infection. However, there is a paucity of literature regarding renal injury in MIS-C. We aim to characterize AKI in MIS-C in this cohort identified at a major children's hospital in New York City during the COVID-19 pandemic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research